Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women

Launched by THE MIRIAM HOSPITAL · Mar 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying an online weight loss program specifically designed for sexual minority women, as they often face unique challenges when it comes to obesity. The program aims to help participants lose weight by addressing issues like stress, social support, and body image. In this trial, 88 women will take part in a 12-week program where they will receive different combinations of tailored support to see which helps them lose weight the most effectively. The researchers will look at how well these new components work in helping women achieve significant weight loss.

To be eligible for this study, participants must be assigned female at birth, identify as female, and self-identify as part of a minority sexual orientation, such as lesbian or bisexual. They should be between the ages of 18 and 70 and have a body mass index (BMI) between 25 and 50, indicating they are struggling with obesity. Participants need regular internet and email access and should be interested in losing weight without having lost a significant amount of weight in the last six months. During the trial, participants will engage in moderate physical activity and will receive support through the online platform. This study aims to create a more effective weight loss program tailored to the needs of sexual minority women.

Gender

FEMALE

Eligibility criteria

• • Assigned female at birth and currently identify as female
• • Self-identify a minority sexual orientation (e.g.,lesbian, bisexual)
• • BMI=25-50kg/m2
• • 18-70 years old
• • Interested in losing weight
• • Regular internet and e-mail access
• • No significant weight loss within past 6 months (\>5%)
• • Fluent in English
• • Able to participate in moderate physical activity
• • Not currently enrolled in a weight loss program
• • Not currently taking weight-loss medication
• • Not currently pregnant or trying to get pregnant
• • Participated in a previous Phase of this study
• • Reports a serious mental/physical health condition that would increase potential risks of treatment to the participant (e.g., active symptoms of psychosis, suicidality, mania, alcohol/substance use, or a medical condition that is serious, active, unstable, and degenerative (e.g., CHF)).